Skip to main content
. 2010 Dec 8;2010(12):CD006387. doi: 10.1002/14651858.CD006387.pub2

MacDougall 1990.

Methods Location of trial: Edinburgh, Scotland.
Number of centres: 1.
Funding: Medical Research Council, Cancer Research Campaign, Scottish Home and Health Department, Lothian Health Board.
Trial ID: not stated.
Participants Inclusion criteria: previously untreated patients with histologically confirmed squamous cell carcinoma of oral cavity, oropharynx, larynx or hypopharynx, less than 80 years old, deemed fit for radiotherapy.
Exclusion criteria: primary tumours with high probability of local control with photon treatment.
Recruitment period: 1977 to 1984.
OC: 66/165 (40%).
OP: 35/165 (21%).
OC+OP: 101/165 (61%).
Number randomised: 165.
Number analysed: 165.
Interventions Fast neutron radiotherapy versus photon radiotherapy
Fast neutron (n = 85): 20 daily fractions over 4 weeks. Total absorbed dose of 15.6 to 16.7 Gy.
Photon (n = 80): 20 daily fractions over 4 weeks. Total absorbed dose 54‐56 Gy.
Outcomes Primary: locoregional control.
Secondary: 5 and 10 year survival, disease free survival at 5 years, cause specific survival, late radiation necrosis.
Duration of follow‐up: minimum of 5 years, up to 11 years.
Notes Sample size calculation: based on predicted increase of locoregional control from 40% to 70% it was estimated that 164 patients would be required to show this difference with power of 90% and α = 0.05 on a tow tailed test of significance.
Part of multicentre trial but full data from 2 centres not available.
Dichotomous data only for outcomes of interest.
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation? Low risk Randomisation stratified on site of primary tumour and presence/absence of malignant lymph nodes. Envelopes containing treatment allocation prepared by trial statistician in Edinburgh, and held by Neutron Clinic secretary.
Allocation concealment? Low risk Sequentially numbered sealed envelopes were drawn.
Blinding ‐ Outcome Assessors High risk Not mentioned.
Incomplete outcome data addressed? Low risk All randomised patients included in analysis.
Free of selective reporting? Unclear risk No planned outcomes listed in methods section. Important outcomes reported.
Free of other bias? Unclear risk Gender imbalance between the groups, unclear if this would introduce a bias.